Novacea and Schering-Plough Prostate Cancer Pact; Remind You of Anyone?
Novacea (NOVC-NASDAQ) is seeing its shares up more than 70% after signing a pact with Schering-Plough (SGP-NYSE) over the development and commercialization of Asentar for the treatment of prostate cancer. Novacea will receive an…